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Outbreak Detection and Epidemiological Surveillance
Anne Holmes,a Lesley Allison,a Melissa Ward,c Timothy J. Dallman,d Richard Clark,b Angie Fawkes,b Lee Murphy,b Mary Hansona
Scottish E. coli O157/VTEC Reference Laboratory (SERL), Royal Infirmary of Edinburgh, Edinburgh, Scotlanda; Wellcome Trust Clinical Research Facility (WTCRF), University
of Edinburgh, Western General Hospital, Edinburgh, Scotlandb; Centre for Immunity, Infection and Evolution, School of Biological Sciences, University of Edinburgh,
Edinburgh, Scotlandc; Gastrointestinal Bacterial Reference Unit, Microbial Services Division, Public Health England, London, United Kingdomd
Detailed laboratory characterization of Escherichia coliO157 is essential to inform epidemiological investigations. This study
assessed the utility of whole-genome sequencing (WGS) for outbreak detection and epidemiological surveillance of E. coliO157,
and the data were used to identify discernible associations between genotypes and clinical outcomes. One hundred five E. coli
O157 strains isolated over a 5-year period from human fecal samples in Lothian, Scotland, were sequenced with the Ion Torrent
Personal GenomeMachine. A total of 8,721 variable sites in the core genome were identified among the 105 isolates; 47% of the
single nucleotide polymorphisms (SNPs) were attributable to six “atypical” E. coliO157 strains and included recombinant re-
gions. Phylogenetic analyses showed thatWGS correlated well with the epidemiological data. Epidemiological links existed be-
tween cases whose isolates differed by three or fewer SNPs. WGS also correlated well with multilocus variable-number tandem
repeat analysis (MLVA) typing data, with only three discordant results observed, all among isolates from cases not known to be
epidemiologically related. WGS produced a better-supported, higher-resolution phylogeny thanMLVA, confirming that the
method is more suitable for epidemiological surveillance of E. coliO157. A combination of in silico analyses (VirulenceFinder,
ResFinder, and local BLAST searches) were used to determine stx subtypes, multilocus sequence types (15 loci), and the presence
of virulence and acquired antimicrobial resistance genes. There was a high level of correlation between theWGS data and our
routine typing methods, although some discordant results were observed, mostly related to the limitation of short sequence read
assembly. The data were used to identify sublineages and clades of E. coliO157, and when they were correlated with the clinical
outcome data, they showed that one clade, Ic3, was significantly associated with severe disease. Together, the results show that
WGS data can provide higher resolution of the relationships between E. coliO157 isolates than that provided by MLVA. The
method has the potential to streamline the laboratory workflow and provide detailed information for the clinical management of
patients and public health interventions.
Shiga toxin-producing Escherichia coli (STEC) strains are im-portant gastrointestinal pathogens and common causes of
acute renal failure in children worldwide (1, 2, 3). In Scotland, the
epidemiology and clinical outcome of E. coli O157 infection in
humans has been closely monitored by Health Protection Scot-
land (HPS) since the introduction of enhanced surveillance in
1999, following a rapid increase in the number of microbiologi-
cally confirmed cases of STEC infection during the mid-1990s.
Enhanced surveillance was extended in 2003 to include non-O157
STEC, and enhanced surveillance of hemolytic-uremic syndrome
(HUS) was established in 2003. The most common STEC sero-
group isolated frompatients in Scotland is E. coliO157. In the past
5 years, the number of culture-confirmed cases of E. coli O157
infection in Scotland ranged from 195 to 263 per year, compared
with 22 to 75 cases of non-O157 STEC infection per year (4, 5). On
average, 43% of the STEC infection cases in Scotland require hos-
pitalization and 9% progress to HUS, mostly in children (5). The
reported rate of E. coli O157 infection in Scotland (4.9 cases per
100,000 population in 2014 [HPS personal communication]) is
higher than in most countries, including other countries within
the United Kingdom (5, 6). The reasons for this are unclear and
likely to be multifactorial but may be related to the relative densi-
ties of human and cattle populations, which are themain reservoir
of E. coli O157. Although large outbreaks of infections associated
with food products have been reported in Scotland (7, 8, 9), the
majority of infections are apparently sporadic, and contact with
animal feces, exposure to farmanimals or farm environments, and
drinking of water from private water supplies have all been iden-
tified as strong risk factors for infection (10, 11).
The continued use of appropriate control measures, which is
dependent on the prompt diagnosis of cases and detection of out-
breaks, is essential to limit the spread of this pathogen. The Scot-
tish Escherichia coliO157/Verotoxigenic E. coli Reference Labora-
tory (SERL) works closely with Scottish National Health Service
(NHS) boards and with HPS and plays a pivotal role in case con-
firmation and outbreak detection by providing identification and
typing services for E. coli O157 and other STEC isolates. Putative
isolates of E. coliO157 are referred to the SERL from all 14 Scottish
health boards for confirmation of identity and typing. In addition,
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fecal samples from cases with typical symptoms of STEC, but cul-
ture negative in local diagnostic laboratories, are sent to the SERL
for further analysis. Currently the SERLuses a range of phenotypic
and genotypic typing techniques, including real-time-PCR, phage
typing, disc diffusion susceptibility testing, multilocus variable-
number tandem-repeat analysis (MLVA), and pulsed-field gel
electrophoresis (PFGE). However, there is an ever-increasing
body of evidence demonstrating the potential benefits of WGS as
a tool thatmay replace thesemethods (12, 13, 14, 15, 16). Bacterial
WGS is becoming increasingly affordable and has demonstrated
better resolution than more conventional typing methods that
sample only a fraction of the genome (17, 18, 19). As a reference
laboratory, it is essential that we continually aim to improve our
services to provide precise and timely data to support public
health interventions. In this study, we have compared our current
methods with WGS for the typing and characterization of E. coli
O157 for epidemiological surveillance and detection of outbreaks.
In addition, we have correlated genome content with pathogenic-
ity and ancestry to try to achieve a better understanding of the
genetic factors associated with virulence in STEC.
MATERIALS AND METHODS
Bacterial isolates. Isolates of E. coli O157 (n  105) from human fecal
samples received in Lothian laboratories between 1 April 2007 and 31
March 2012 were analyzed in this study (see Table S1 in the supplemental
material). These included isolates from 10 cases received over an 11-
month period in 2011 associated with a United Kingdom-wide outbreak
that was linked to unwashed vegetables (20), isolates that were epidemi-
ologically linked by place and time (eight single-household clusters, one
cluster involving two households that was farm related, and one travel-
associated cluster), and sporadic isolates from 27 patients thought to have
acquired their infections outside the United Kingdom. The patients had
all been interviewed by using standardized questionnaires to collect infor-
mation, including severity of infection and travel history, to identify any
epidemiological links and try to pinpoint the source of infection. The ages
of the patients sampled ranged from 1 to 85 years, with a gender distribu-
tion of 42% male and 58% female.
DNA isolation. E. coliO157 isolates were incubated overnight at 37°C
on sorbitolMacConkey agar (Oxoid Ltd., Basingstoke, United Kingdom).
DNAwas extracted with theWizard Genomic DNA purification kit (Pro-
mega Ltd. UK, Southampton, United Kingdom) as described by theman-
ufacturer. The quality of the genomic DNA (gDNA) was checked by gel
electrophoresis, and the quantity and purity were measured with the
NanoDrop 1000 apparatus (NanoDrop Products, Thermo Scientific).
Phenotypic testing. Phage typing was performed with 16 phages as
previously described (21). -Glucuronidase (-GUD) production was
assessed by using TBX agar (tryptone bile X-glucuronide agar; E&O Lab-
oratories); ATCC 25922 was used as a control strain. Antibiotic sensitivity
patterns were determined by the disc diffusionmethodwith 15 antibiotics
routinely tested in the SERL for surveillance purposes: chloramphenicol,
ciprofloxacin, ampicillin, gentamicin, streptomycin, meropenem, nali-
dixic acid, kanamycin, tetracycline, trimethoprim, piperacillin-tazobac-
tam, cefotaxime, ceftazidime, co-amoxiclav and co-trimoxazole. The
European Committee on Antibiotic Susceptibility Testing (EUCAST) cri-
teria were used to determine resistance.
MLVA.MLVA was performed as previously described (22). Raw data
(.fsa files) from an ABI 3130 genetic analyzer (Applied Biosystems) were
imported and analyzed in BioNumerics v6.6 (Applied Maths, Sint-Mar-
tens-Latem, Belgium) with the MLVA plugin. A minimum spanning tree
was produced with the MLVA allele numbers.
Shiga toxin gene subtyping. PCR assays and gel electrophoresis were
performed as described by Scheutz et al. (23), with a fewmodifications. A
sample volume of 15 l with a HotStarTaq master mix kit (Qiagen UK
Ltd., Crawley, United Kingdom), 0.2 M primer(s), and 1.5 l of DNA
was used. stx1a, stx1c, and stx1d primers were multiplexed in a single reac-
tion mixture. stx2 primers for stx2b, stx2e, and stx2g were multiplexed,
while stx2a, stx2c, stx2d, and stx2f were used in singleplex reactionmixtures.
The thermocycler conditions were 95°C for 15 min and then 35 cycles of
94°C for 50 s, 66°C for 40 s, and 72°C for 3 min. Amplicons were run on a
2% agarose gel.
WGS. WGS was performed with the Ion Torrent Personal Genome
Machine (PGM; Life Technologies, Carlsbad, CA) at the Wellcome Trust
Clinical Research Facility, Edinburgh, Scotland. Samples were sequenced
retrospectively over a period of1 year on the samemachine by the same
personnel and analyzed with the same version of the software to limit the
effects of batching. Libraries were generated with 1 g of the gDNA and
enzyme fragmented with the Ion XpressPlus Fragment Library kit. Spe-
cifically, gDNA was fragmented into 200- to 300-bp blunt-ended DNA
fragments. The fragmented DNA was ligated to Ion Torrent-compatible
barcoded adapters; this was followed by nick repair to complete the link-
age between the adapters and DNA inserts. The adapter-ligated library
was then size selected for optimum length (330 bp), and the final library
was amplified. An aliquot of the library was analyzed on the Bioanalyzer
instrument with an Agilent High Sensitivity DNA kit to assess the size
distribution and determine the molar library concentration. Two bar-
coded libraries were pooled at a concentration of 100 pM, and a 10 pM
portion of the pool was added into an emulsion PCR-based template
reactionmixture; in this reactionmixture, the fragments generated during
library preparation were attached to Ion Sphere particles (ISPs) and clon-
ally amplified. This process was carried out with the Ion One Touch 2
system and the Ion PGM Template OT2 200 kit. Quality control was
performed on the Qubit 2.0 fluorometer with the Ion Sphere Quality
Control assay. The optimal amount of library corresponds to the library
dilution that gives template ISP percentages of 10 to 30%. The template-
positive ISPs were then enriched and sequenced on the PGMwith the Ion
PGM Sequencing 200 kit v2 and an Ion 316 chip. Average coverage was
determined by using an estimated genome size of 5.528 Mb and found to
be 42 (range, 23 to 106; see Table S1 in the supplemental material).
Bioinformatics. Sequence reads were mapped to the reference strain
(Sakai, GenBank accession no. NC_002695) with BWA-MEM (24), and
isolates with an average coverage of20 were excluded from the anal-
ysis. Single nucleotide polymorphisms (SNPs) were then identified with
GATK2 (25) in unified genotyper mode. Core genome positions (defined
as sites for which a base was called for all isolates) that had a high-quality
SNP (90% consensus, minimum depth of 10, genotype quality score
of30) or were the same as the reference base were extracted to produce
awhole-core genome alignment for phylogenetic analysis. Sequence reads
were also assembled de novo with the Torrent Suite Software, and the
assemblies (contigs) were used for in silico analysis as described below.
In silico analysis. Local BLAST databases were developed in either
BioEdit (http://www.mbio.ncsu.edu/bioedit/bioedit.html) or BioNumerics
v6.6 (AppliedMaths) for multilocus sequence typing (MLST), stx subtyp-
ing, virulence gene detection, and lineage-specific polymorphism assay
(LSPA-6) typing. The databases were then queried with the de novo as-
semblies. ForMLST, the database consisted of the alleles of 15 housekeep-
ing genes (arcA, aroE, aspC, clpX, cyaA, dnaG, fadD, grpE, icdA, lysP,mdh,
mtlD,mutS, rpoS, uidA), which were downloaded from the EcMLSTweb-
site (www.shigatox.net/ecmlst/cgi-bin/index); for stx subtyping, the data-
base consisted of 600-bp sequences (342 bp of the C-terminal part of
subunit A and 258 bp of the N-terminal part of subunit B) of 106 stx
variants used by Scheutz et al. (23). For LSPA-6 typing, partial gene se-
quences of the six genes (folD-sfmA, Z5935, yhcG, rbsB, rtcB, and arp-iclR)
were extracted from strain Sakai and used to form the database (26, 27).
Isolates with genotype 111111 were classified as LSPA-6 lineage I, those
with genotype 211111 were classified as LSPA-6 lineage I/II, and those
with other derivations were classified as LSPA-6 lineage II.
Strains belonging to clade 8 (28) were identified on the basis of the
discriminatory SNP (C/A at position 539 in gene ECs2357) described by
Riordan et al. (29).
Holmes et al.
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VirulenceFinder and ResFinder (http://cge.cbs.dtu.dk/services/) were
used to determine the presence of E. coli virulence genes and acquired
antibiotic resistance genes with identity thresholds of 85 and 98%, respec-
tively (30, 31).
Data analysis. Ridom EpiCompare (http://www3.ridom.de/epico
mpare/) was used to calculate the discriminatory power of the typing
methods. Odds ratios (ORs) were calculated with MedCalc (http://www
.medcalc.org/calc/odds_ratio.php).
Recombination detection. The number of variable sites across the core
genomealignmentwascalculated in slidingwindowsof10,000bpandplotted
by using customPython andR scripts to identify areas of the genomewith an
unusually high density of SNPs. The entire E. coli O157 core genome align-
ment was screened for recombination with BratNextGen (32) and also
screened for recombinationwithBratNextGenwhen the twohighlydivergent
and putative recombinant sequences (XH18570E and XH22083W) were ex-
cluded from the alignment.
Maximum-likelihood phylogenetic analysis. Maximum-likelihood
core genome phylogenies were constructed with the RaxML software (33;
Linux version 8) and PhyML (34). For the published RaxML phylogeny,
the general time-reversible model of nucleotide substitution was used,
with gamma-distributed rate heterogeneity across sites and 1,000 boot-
strap replicates. Neighbor-joining phylogenies were also produced with
MEGA version 5 (35). We confirmed that the tree topology was robust to
the use of different software frameworks, as well as different choices of
evolutionary model. In the absence of an obvious outgroup to O157,
phylogenies were rooted at the midpoint between the two most divergent
taxa in the trees.
Nucleotide sequence accession numbers. FASTQ sequences were
deposited in the NCBI Sequence Read Archive under BioProject no.
PRJNA283577 (http://www.ncbi.nlm.nih.gov/bioproject/PRJNA283577/).
RESULTS
Analysis of core genome.Our core genome alignment of the 105
E. coli O157 strains was 4,122,236 bp in length and contained
8,721 variable sites. However, a large number (4,110; 47%) of the
SNPs were attributable to six “atypical” E. coliO157 strains, includ-
ing a sorbitol-fermenting (SF) E. coli O157 strain (XH25052C)
and three -GUD-positive E. coli O157 strains (XH20443W,
XH16200L, and XH24967A). When looking across the whole
alignment, an 150-kb region with a high density of SNPs (an
average of 148.33 variable sites per 10,000-bp window, compared
to a genome-wide average of 21.16 variable sites per 10,000-bp
window) was observed near the end of the genome. Two of the
atypical strains (XH18570E and XH22083W) were identified by
the BratNextGen software as recombinant in this region, suggest-
ing that genetic material has entered from a donor strain. See Fig.
S1 in the supplemental material for plots of the distribution of
variable sites across the genome in the presence and absence of
recombinant strains XH18570E and XH22083W, as well as with
and without recombinant regions excluded. Sanger sequencing of
792 bp of the mutL gene, which lies within the putative recombi-
nant region, confirmed that the SNPs detected byWGS were gen-
uine, and a BLAST analysis of this gene region showed that it was
identical to themutL gene of E. coli K-12.
Removal of recombinant strains XH18570E and XH22083W
from the alignment, followed by the removal of additional, small,
putative recombinant regions identified by BratNextGen for other
strains, resulted in a 4,114,451-bp alignment containing 6,626
variable sites.
Epidemiological concordance. Eleven groups of two ormore
isolates known to be epidemiologically linked were present in
our analysis, and the epidemiologically linked isolates formed
clusters with 100% bootstrap support in the core genome phy-
logeny (Fig. 1). Within each epidemiologically linked cluster,
there were fewer than four core SNPs separating the isolates.
Three SNPs were identified among 10 isolates from a United
Kingdom-wide phage type 8 (PT8) outbreak spanning 11
months in 2011. A maximum of two SNPs were identified
among isolates from the other epidemiologically linked cases
received by the SERL within a shorter time frame (0 to 14 days).
The SNPs detected among epidemiologically related cases were
confirmed by Sanger sequencing. For the SNP distances be-
tween all of the pairs of isolates, see Table S2 in the supplemen-
tal material. In three instances, isolates from cases with no
apparent epidemiological link clustered together in the core
SNP phylogeny and were separated by a maximum of 1 SNP. In
two cases (XH11963F with XH12059K and XH15449Q with
XH15521V), the isolates were temporally related (isolated
within 8 days), had the same MLVA profile, and did not differ
at any core SNP positions (i.e., their core genome sequences
were identical), suggesting that there may have been an un-
identified common source of infection. Another isolate
(XH16734G) clustered with XH15449Q and XH15521V (dif-
fering from those isolates by one SNP) but was an MLVA dou-
ble-locus variant (DLV) and was isolated 4 months later. In
the third case (XH11856D with XH12193B), the two isolates
differed by one SNP and clustered in the core genome phylog-
eny with 100% bootstrap support,wereMLVAsingle-locus variants
(SLVs), and were isolated 39 days apart. Two additional MLVA
SLVs (XH14013BwithXH17884GandXH14653VwithXH18908N)
were observed in the data set; however, they were not related in
time or space anddiffered by 36 and 126 SNPs, indicating that they
were not closely related. The genetic variation among all pairs of
isolates with no epidemiological links was 9 to 1,632 SNPs (see
Table S2 in the supplemental material).
Concordance with MLVA and phage typing. A comparison
of the minimum spanning tree produced by MLVA and the
phylogeny based on the core genome showed that, although
epidemiologically linked isolates clustered together in both
trees, the overall topologies and the clustering of epidemiolog-
ically unrelated isolates differed between the trees. Within the
core genome phylogeny, all of the sublineages we defined, and
the majority of the clades within these were supported by boot-
strap values of 100% (see Fig. S2 and S3 in the supplemental
material). In contrast, the minimum spanning tree based upon
the MLVA data (see Fig. S4 in the supplemental material) had
relatively low bootstrap values, suggesting that MLVA provides
meaningful phylogenetic relationships only for closely related
isolates. Similarly, although phage typing was broadly congru-
ent with the core genome phylogeny, identical PTs were dis-
tributed across the core genome phylogeny in different clades
(Fig. 1). For example, PT4 was distributed in four of our de-
fined sublineages across the tree, suggesting a lack of specificity
of phage typing.
Discriminatory power of typingmethods. The SNP data sep-
arated the 105 isolates into 81 different types (Simpson’s index of
diversity [SID], 0.989; 95% confidence interval [CI], 0.979 to
0.998), where isolates that differed by more than three SNPs were
considered to be of different types. MLVA produced 80 different
allelic profiles (SLVs were considered to be of the same type) and
had the same discriminatory index as the SNP method (SID,
0.989; 95%CI, 0.979 to 0.998). The types were concordant, except
for the two sets of MLVA SLV’s that fell in different parts of the
WGS of E. coli O157
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core genome phylogeny and isolate XH16734G, which differed at
two MLVA alleles (VNTR3 and VNTR9 by one repeat) from
XH15449QandXH15221V (Fig. 1; see Table S1 in the supplemen-
tal material). Phage typing produced 14 different lysis patterns
and had a much lower SID than the other two methods (SID,
0.853; 95% CI, 0.817 to 0.89).
stx subtyping. The stx subtypes were determined by PCR and
in silico analyses. A relatively low diversity of subtypes was de-
FIG 1 Maximum-likelihood core genome phylogeny for 103 E. coliO157 isolates from Lothian, Scotland. Recombinant sequences XH18570E and XH22083W
were excluded. The tree was constructed with RAxML by using a general time-reversible model of nucleotide substitution and gamma distributed rate hetero-
geneity across sites. Branch lengths are in numbers of substitutions per site. Isolates known to be epidemiologically related (Epi) are in the same color. MLVA
types shared by more than one isolate are indicated by filled boxes of the same color; SLVMLVA types are indicated by checkered boxes of the same color. PTs,
multilocus STs, LSPA-6 types, stx subtypes, and the number of antibiotics (out of 15 tested) towhich an isolate was resistant (AB len.) are shown. RDNC indicates
that the PT reaction did not conform to a recognized pattern. Isolates associated with recent travel are in blue (Travel). All Lothian isolates were associated with
diarrhea; isolates associated with bloody diarrhea (BD), hospitalization (H), and/or HUS are in red. Sublineages, defined as described in the text, are indicated
by vertical black bars. One thousand bootstrap replicates were conducted, and bootstrap values of 98%, for nodes corresponding to the major lineages and
sublineages described in the text, are indicated by asterisks.
Holmes et al.
3568 jcm.asm.org November 2015 Volume 53 Number 11Journal of Clinical Microbiology
 o
n
 N
ovem
ber 12, 2015 by UNIVERSITY O
F EDINBURG
H
http://jcm.asm.org/
D
ow
nloaded from
 
tected among the 105 isolates (Fig. 1; see Table S1 in the supple-
mental material). The most common subtype was stx2a/stx2c
(n 42), followed by stx2c only (n 26) and stx1a/stx2c (n 24).
Eleven isolates carried stx2a only, while two had stx1a only.
The PCR results were concordant with the local BLAST and
VirulenceFinder results for 102 (97%) and 97 (92%) isolates, re-
spectively. The local BLAST search did not detect the stx2c gene in
three isolates found to carry stx2a and stx2c by PCR; in one case,
only a partial sequence was identified, while in another, two dif-
ferent stx2a subtypes were detected. VirulenceFinder produced
similar results for these isolates; however, in one case, it detected
the presence of an stx2c subunit A but the adjacent subunit B was
reported as stx2a. Similarly, in four other cases, VirulenceFinder
detected different stx2 variants in subunits that lay beside each
other in the genome. In one case, a stx2d subunit A was reported in
one isolate, which was not detected by PCR assay or the local
BLAST search.
Virulence gene detection. VirulenceFinder and local BLAST
searches were used to determine the presence of virulence genes;
for a complete list of the genes detected in each isolate, see Table S1
in the supplemental material. A total of 23 virulence genes were
detected among the 105 isolates. Twenty of the genes (astA, eae,
ehxA, espA, espB, espF, espJ, espP, etpD, gad, iha, iss, katP, nleA,
nleB, nleC, prfB, tccP, tir, and toxB) were present or partially pres-
ent (85% of the gene detected; see Table S1 in the supplemental
material) in the majority (94%) of the isolates. In six isolates, one
or more of these genes were not detected (see Table S1). These
were the four “atypical” E. coli isolates (XH16200C, XH20443W,
XH24967A, and XH25052C), one isolate that was negative
for espP (XH12849W), and another that was negative for iha
(XH14120C). The three remaining genes, cdtB, cba, and celB, were
found in only a small proportion of the isolates.
The presence of eae and hly was detected by PCR in all of the
study isolates; however, VirulenceFinder failed to detect these
genes in 8 and 10 cases, respectively (see Table S1). The discordant
results were further analyzed by performing local BLAST searches
of these genes against the de novo assemblies. These revealed that
the genes were present in all of the strains but were split among
two or more different contigs, which explains why they were not
detected by VirulenceFinder. Also, in some cases, part of the gene
sequence was duplicated in the different contigs. For example, for
XH11963F, bases 1 to 1602 of eae were present in contig c122 and
bases 1388 to 2805 were present in contig c131, resulting in an
overlap of 125 bp in the middle of the gene. The fractured and
duplicated nature of these assemblies may be suggestive of low
coverage in these areas, resulting in poor assembly.
Ten other genes not tested by PCR (espF, espP, nleC, iha, katP,
toxB, tccP, cba, celB, cdtB) were further investigated by local
BLAST searches, as they were not detected by VirulenceFinder in
at least one of the isolates. The results of the local BLAST searches
matched the VirulenceFinder results in the majority of the cases
(313/413), where the genes were also not detected by the local
BLAST searches. In 10 cases, only partial genes (85% of the
gene) were detected, while in 90 cases, the genes were present in
multiple contigs, explaining why they were not detected by
VirulenceFinder. Most notably, tccP was not detected in 75/105
cases because of its presence in multiple contigs (see Table S1 in
the supplemental material). tccP can vary in length and contains
proline-rich repeats (36), which are difficult to resolve by using
short sequence reads, explaining its presence in multiple contigs
and the failure of VirulenceFinder to detect this gene in most of
the isolates.
Antimicrobial resistance gene detection. The isolates were
tested for susceptibility to 15 different antimicrobial agents be-
longing to six different antimicrobial classes. A relatively low level
of resistance was detected (Fig. 1; see Table S1 in the supplemental
material); 15 (14%) out of 105 isolates showed resistance to one or
more antibiotics. Streptomycin (n  14), sulfamethoxazole
(n  14), and tetracycline (n  9) were the antibiotics to which
resistance was most frequently observed. Two isolates were resis-
tant to six antibiotics: ampicillin, kanamycin, sulfamethoxazole,
streptomycin, tetracycline, and trimethoprim.Wedid not observe
an association between antimicrobial resistance and foreign travel
(OR, 1.2; P 0.7753). There were no disagreements between the
observed and predicted susceptibility patterns; however, pheno-
typic and genotypic resistance to several antibiotics (ampicillin,
sulfamethoxazole, streptomycin, trimethoprim-sulfamethoxa-
zole, and trimethoprim) was observed in one isolate that was ep-
idemiologically linked to a strain in which no resistance was
detected (XH18778Q and XH18795X; see Table S1 in the supple-
mental material). This may be related to the loss or gain of an
unstable plasmid carrying the resistance genes.
MLST. Ten different multilocus sequence types (STs) were
identified among the 105 strains (Fig. 1). ST23 was the most com-
mon type (n  56), followed by ST118 (n  22) and ST24
(n  14). The three -GUD-positive strains belonged to ST84
(ST65 seven-locus scheme), while the SF E. coli O157 strain was
ST76, which corresponds to previous reports (37). Five new STs
were identified, as they differed by at least one SNP, in one ormore
alleles, from those present in the EcMLST database. Also, in four
strains, a single nucleotide gap/no call was detected in one of the
alleles (see Table S1 in the supplemental material). Inspection of
the sequence reads at these positions showed that the base was
present in only about one-third of the reads and so would have
been excluded during minimum variant frequency filtering. As
expected, the ST correlated well with the core genome phylogeny.
Evolutionary analysis ofE. coliO157.Figure 1 shows themax-
imum-likelihood phylogeny constructed from the core genome
alignment of the O157 strains. The atypical strains (SF and
-GUD positive) cluster together and are phylogenetically dis-
tinct from the -GUD-negative E. coliO157 strains isolated from
the majority of Lothian patients in recent years. The rest of the
phylogeny can be divided into three clades that correspond to
recently described lineages I, I/II, and II (38). As noted byDallman
et al., LSPA-6 typing does not adequately resolve these lineages;
the folD-sfmA polymorphism does not differentiate lineages I and
II. The lineages can be further divided into sublineages with dis-
tinct genotypic andphenotypic characteristics. As indicated in Fig.
1, the bootstrap values for all of the lineages and sublineages were
greater than 98% (with the majority being 100%), indicating a
high level of support for the clusters observed. A strong concor-
dance was noted between the lineages defined in the phylogeny
and the clusters inferred from the proportion of shared ancestry
tree in the BratNextGen analysis (see Fig. S2 in the supplemental
material). Sublineage IIa consists of ST24 strains, or ST24 SLVs,
that carry stx2c only and consist of PT34, PT49, and PT54. Sublin-
eage IIb is a heterogeneous group with respect to the PT and stx
profile, while sublineage IIc consists of ST118 PT8 strains that
have acquired stx1a. Fifty-seven percent of the strains associated
with antimicrobial resistance (antibiogram length of 1) were
WGS of E. coli O157
November 2015 Volume 53 Number 11 jcm.asm.org 3569Journal of Clinical Microbiology
 o
n
 N
ovem
ber 12, 2015 by UNIVERSITY O
F EDINBURG
H
http://jcm.asm.org/
D
ow
nloaded from
 
present within lineage IIc. Lineage I/II consists of ST24 PT4 and
PT2 strains carrying either stx2a only or both stx2a and stx2c, re-
spectively, and belonging to clade 8 (see Table S1 in the supple-
mental material) that have been associated with large outbreaks of
severe disease in the United States (28). Lineage I strains belong to
ST23 and consist of three main sublineages (Ia, Sakai; Ib, stx2c-
only genotype; and Ic) that can be further subdivided into three
main clades. The largest, named Ic3 here, consists predominately
of PT21/28 stx2a and stx2c strains that are responsible for the ma-
jority of the human infections reported in Scotland and theUnited
Kingdom (5). Of note, no isolates in this clade were associated
with acquired antimicrobial resistance or foreign travel.
Correlation of genotype with disease severity. The enhanced
surveillance data showed that all 105 (100%) patients had diar-
rhea, 64 (61%) had bloody diarrhea, 30 (29%) were hospitalized,
and 10 (9%) developed HUS. Six (60%) of the 10 HUS cases were
in children 16 years old (see Table S1 in the supplemental ma-
terial). No deaths were recorded.
Seven (70%) of the 10 HUS cases were associated with geno-
type Ic3. Statistical analysis of the results showed a significant
association between Ic3 and HUS (OR, 4.5938; P  0.0351). Ic3
was also significantly associated with hospitalization (OR, 3.1503;
P 0.0103) but not bloody diarrhea (OR, 2.1212;P 0.0826).No
significant correlations between the other genotypes and clinical
outcomes were observed; however, some tests were based upon
very small numbers of samples, making it difficult to determine
statistically meaningful results.
Ic3 strains carry stx2a (and usually stx2c), and previous reports
have suggested that stx2a is associatedwith increased virulence and
more severe human disease (39, 40). We found that 8 (80%) of 10
isolates fromHUS cases carried the stx2a gene; however, statistical
analysis showed that the presence of stx2a was not significantly
associated with HUS (OR, 4.4444; P 0.0678) or hospitalization
(OR, 2.0829; P  0.0986), suggesting that other features of 1c3
and/or host factors are likely to be important in the development
of severe complications of infection.
DISCUSSION
Two of the most important features of a typing method are its
ability to distinguish between unrelated strains and to correctly
classify epidemiologically related isolates from an outbreak or
cluster as part of the same clone (41). This study showed that the
identification of core genome SNPs following WGS provided a
highly discriminatorymethod for subtyping ofE. coliO157, giving
results concordant with the epidemiological data. The method
was also concordant with MLVA for the identification of epide-
miologically linked cases, even though different areas and a much
smaller percentage of the genome were targeted by MLVA, dem-
onstrating the value of MLVA for outbreak detection. A recent
study carried out by Public Health England (PHE) showed that
MLVA was as sensitive as WGS for identifying linked cases of E.
coliO157 infection but, because of the time taken to determine the
relatedness of MLVA DLVs occasionally observed in larger out-
breaks, found that WGS resolved all of the cases in a cluster faster
(42). In this study, among the isolates with no known epidemio-
logical links, there were three discordant results between MLVA
andWGS. In one case, anMLVADLVwas shown to differ by only
one SNP from two other isolates (that were identical byWGS and
MLVA), while in two cases, the WGS data showed that MLVA
SLVs were not, in fact, closely related in terms of the core genome.
We currently useMLVAprofiles (exactmatches and SLVs) to alert
health protection teams and HPS of putative linked cases, which
are then further investigated for epidemiological links. Together,
the data suggest that WGS may provide more precise data and
reduce the unnecessary deployment of health protection re-
sources in the investigation of putatively linked isolates. Tura-
belidze et al. (14) showed that a cluster of E. coliO157 cases asso-
ciated with the consumption of romaine lettuce and salad bar
exposures was better resolved by using core genome SNPs than by
using MLVA and PFGE.
The determination of SNP distances between strains showed
that some diversity existed among isolates from epidemiologically
linked cases. We found three or fewer SNP differences among
isolates from known epidemiologically linked cases. Definition of
variation is important for the assessment of relatedness and estab-
lishment of a targeted approach to case inclusion in outbreaks and
contact tracing. Others have reported SNP diversity among epide-
miologically related cases. Dallman et al. (42) found five or fewer
SNP differences among 183 epidemiologically related isolates
from different clusters received by PHE, Underwood et al. (17)
detected four SNP differences among 16 isolates of E. coli O157
isolated during a farm outbreak, and Joensen et al. detected seven
SNP differences among six outbreak cases (30). Various factors
may explain the degree of genomic variation reported in different
outbreaks, including the strains sampled, outbreak duration, the
sequencing platforms used, and the criteria used to define high-
quality SNPs.
In the past, considerable effort has beenmade to standardize E.
coli typing methods to enable comparisons of data produced in
different laboratories (e.g., PulseNet, CDC). The standardization
of MLVA between reference laboratories in the United Kingdom
has been invaluable for the rapid detection of cross-border out-
breaks (22), and this study has confirmed its utility in outbreak
detection. It is likely that the standardization of data produced by
WGS in different laboratories will be a major challenge and re-
quire considerable collaboration between clinical and reference
laboratories.
A major advantage of WGS is its ability to produce a well-
supported, high-resolution phylogeny and therefore an appropri-
ate method for understanding or tracking the evolutionary
relationships between strains and for detailed epidemiological
surveillance of E. coli O157. Although the isolates sequenced in
this study were from a single Scottish health board, phylogenetic
analysis revealed a population structure remarkably consistent
with that in previous studies, in particular, work recently carried
out at PHE, where a large number of strains of E. coli O157 (n
1,075) from clinical and animal sources collected over a 29-year
period in the United Kingdom were analyzed (38). All lineages
and sublineages, except Ia, were represented in our strain collec-
tion. Similar to the PHE study, the main clusters within lineages I,
I/II, and II consisted of isolates belonging to the PTs commonly
associated with human disease in the United Kingdom, PT21/28,
PT2, and PT8, respectively.
Another major advantage of WGS is the additional informa-
tion that can be extracted, including important virulence and an-
tibiotic resistance determinants. We were able to correctly infer
antibiotic susceptibility profiles from the WGS data, suggesting
that WGS is a suitable alternative to current routine laboratory
testing for the surveillance of antimicrobial resistance and the de-
tection of emerging resistance phenotypes. Resistance to strepto-
Holmes et al.
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mycin, sulfamethoxazole, and tetracycline was most often ob-
served, consistent with previous reports (43, 44, 45), most likely
because of the selection pressure imposed by the use of these
agents in clinical and veterinary medicine.
Using the genes present in the VirulenceFinder database (76
genes plus variants), we found limited variation in gene content
among the isolates. Differences were observed mostly among the
atypical isolates because of the carriage of different plasmids. For
example, ST76 SF E. coli O157 did not carry espP, katP, and toxB,
which is consistent with the carriage of the pSFO157 plasmid (46).
This strain also did not carry espF, iha, and tccP but harbored cdtB.
Eklund et al. (47) found most SF E. coli strains to possess the gene
cluster (cdtV) encoding the cytolethal distending toxin family,
which includes cdtB. Among the NSF E. coli O157 isolates, we
found cdtB exclusively within sublineage Ib, so it may be suitable
for use as a marker for this sublineage.
Although the virulence genes were detected with a high degree
of accuracy, somediscordant results were observed,mostly related
to the limitation of short sequence read assembly to resolve repeat
regions and, in some cases, low read depth resulting in poor as-
semblies. The sensitivity of in silico detection software, such as
VirulenceFinder, depends upon the use of high-quality assem-
blies, and assembly efficiency is dependent on read depth across
the whole genome. Jünemann et al. (48) compared benchtop se-
quencers to show that the optimal coverage (based onN50 values)
with sequencing data generated by the PGM andMiSeq was40-
and 75-fold, respectively, while Desai et al. (49) reported that the
coverage required to produce a good assembly was dependent on
the assembly software used; however, 50was optimal formost of
the widely used software (e.g., Velvet, SOAPdenovo, and AbySS)
to assemble an E. coli genome with Illumina reads. Other gene-
finding software (e.g., Ridom SeqSphere) suggests a minimum
coverage of50 for PGM data and75 for MiSeq data (Ri-
dom GmbH, Münster, Germany). In this study, the average read
depth ranged from 23 to 106 (see Table S1 in the supplemental
material); therefore, in some cases, optimal coverage was not ob-
tained, explaining, in part, the failure of VirulenceFinder to detect
some genes. However, a gene-finding method that does not con-
sider each contig separately may make better use of the available
sequencing information.
The VirulenceFinder database also contained the stx genes as
individual subunit sequences rather than holotoxins; however, the
combination of both subunit sequences is essential for accurate
differentiation of the subtypes, explaining why, in some cases, two
subunits lying adjacent to each other were reported as different stx
subtypes. It is essential that the stx genes can be accurately detected
and characterized, as they play an essential role in the develop-
ment of disease and some studies (38, 39, 40) have found that
certain subtypes (e.g., stx2a) have been associated with increased
pathogenicity.WGShas the advantage of being able to detectmul-
tiple stx genes of the same subtype, which is not possible by PCR.
For example, in one strain, we detected two different stx2a gene
variants. Recently, Ashton et al. (50) used a combined mapping
and de novo approach to detect multiple genes of the same stx
subtype in15% of the isolates tested. In this study, we may have
underestimated the number of isolates with multiple genes of the
same subtype, as the bioinformatics approach used may not have
detected these. The significance of the presence of multiple genes
of the same stx subtype is unknown and needs further investiga-
tion.
It is currently not possible to determine MLVA types from
WGS data because of short read lengths; however, with advances
in technology such as single-molecule real-time sequencing (e.g.,
PacBio) (51) and nanopore sequencing (52), which provide lon-
ger read lengths capable of spanning tandem repeat regions, this
information will be captured and will be available to help define
the evolutionary relationships of isolates. The molecular basis of
phage typing is also not known, so it is currently not possible to
extract PT from WGS data. MLST types were successfully deter-
mined in silico. Although the 15-locus scheme provides a low level
of resolution, there are various softwares (Applied Maths, Ridom
SeqSphere, BIGSdb) available for whole-genomeMLST, enabling
the analysis of thousands of genes. It is thought that whole-ge-
nome MLST will be easier to standardize than core SNP analysis
and enable a hierarchical approach to be used (53); however, the
method requires allele curation and may be less discriminatory.
The development of improved software to overcome the limi-
tations of short read assembly is required to realize the potential of
WGS for in silico data analysis. Precise knowledge and under-
standing of the genome contents of the strains causing clinical
infections should enable the identification of risk factors for im-
proved patient management.We have shown that Ic3 strains were
significantly associated with severe disease; however, contrary to
recentwork (38), we did not find carriage of stx2a to be essential for
the development of HUS. Further in-depth analysis of these Ic3
strains is required to determine features likely to be important in
the development of severe disease.
Overall, we have demonstrated that WGS offers the potential
to streamline reference laboratory processes by the use of a single
diagnostic tool to generate the information required to support
the clinical management of cases and public health investigations
and interventions to control disease spread. It has the potential to
transform the way we assess the relatedness of strains and the risk
of development of severe complications. However, issues relating
to ease of performance and standardization, aswell as information
technology infrastructure and data storage, need to be addressed
before it is introduced routinely.
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